Otrivine Extra Dual Relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution Malta - English - Medicines Authority

otrivine extra dual relief 0.5 mg/ml + 0.6 mg/ml nasal spray, solution

haleon hellas single member societe anonyme, under the distinctive title of haleon hellas, 274, kifissias ave, 15232 chalandri, athens, greece - xylometazoline hydrochloride, ipratropium bromide - nasal spray, solution - ipratropium bromide 0.6 mg/ml xylometazoline hydrochloride 0.5 mg/ml - nasal preparations

Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml nasal spray Malta - English - Medicines Authority

otrivine extra dual relief 0.5mg/ml + 0.6mg/ml nasal spray

novartis consumer health uk limited - xylometazoline hydrochloride; ipratropium bromide - nasal spray, solution - xylometazoline hydrochloride 0.5 mg/ml; ipratropium bromide 0.6 mg/ml - nasal preparations

OTRIVIN COMPLETE Israel - English - Ministry of Health

otrivin complete

gsk consumer healthcare, israel ltd - ipratropium bromide; xylometazoline hydrochloride - nasal spray, solution - ipratropium bromide 0.6 mg/ml; xylometazoline hydrochloride 0.5 mg/ml - ipratropium bromide - symptomatic treatment of nasal congestion and rhinorrhea in connection with common cold in adults.

Otrivine Extra Dual Relief 0.5mg/ml + 0.6mg/ml nasal spray, solution Ireland - English - HPRA (Health Products Regulatory Authority)

otrivine extra dual relief 0.5mg/ml + 0.6mg/ml nasal spray, solution

haleon ireland limited - xylometazoline hydrochloride; ipratropium bromide - nasal spray, solution - 0.5mg /ml + 0.6mg/ml milligram(s)/millilitre - sympathomimetics, combinations excl. corticosteroids; xylometazoline

OTRIVINE EXTRA DUAL RELIEF 0.5/0.6 Mg/Ml Nasal Spray Solution Ireland - English - HPRA (Health Products Regulatory Authority)

otrivine extra dual relief 0.5/0.6 mg/ml nasal spray solution

novartis consumer health uk limited - ipratropium bromide xylometazoline hydrochloride - nasal spray solution - 0.5/0.6 mg/ml

Otrivine Duo 0.5 mg/ml - 0.6 mg/ml nas. spray sol. spray cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

otrivine duo 0.5 mg/ml - 0.6 mg/ml nas. spray sol. spray cont.

haleon belgium sa-nv - ipratropium bromide 0,6 mg/ml; xylometazoline hydrochloride 0,5 mg/ml - nasal spray, solution - 0,5 mg/ml - 0,6 mg/ml - ipratropium bromide 84 µg/dose; xylometazoline hydrochloride 70 µg/dose - xylometazoline

Xymelin Extra spray nasal Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

xymelin extra spray nasal

takeda gmbh - xylometazoline (xylometazoline hydrochloride), ipratropium bromide (ipratropium bromide monohydrate) - spray nasal - 84mcg/dose+ 70mcg/dose

Xymelin Extra spray nasal Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

xymelin extra spray nasal

takeda gmbh - xylometazoline (xylometazoline hydrochloride), ipratropium bromide (ipratropium bromide monohydrate) - spray nasal - 84mcg/dose+ 70mcg/dose

OTRIVIN PLUS nasal spray pump actuated metered dose aerosol Australia - English - Department of Health (Therapeutic Goods Administration)

otrivin plus nasal spray pump actuated metered dose aerosol

haleon australia pty ltd - xylometazoline hydrochloride, quantity: 0.5 mg/ml; ipratropium bromide monohydrate, quantity: 0.6 mg/ml - spray, nasal - excipient ingredients: purified water; hydrochloric acid; disodium edetate; glycerol - short term use for the symptomatic relief of nasal congestion and rhinorrhoea associated with the common cold and allergic rhinitis (eg. hayfever).

Otrivin Plus Nasal Spray New Zealand - English - Medsafe (Medicines Safety Authority)

otrivin plus nasal spray

haleon new zealand ulc - ipratropium bromide 0.6 mg/ml; xylometazoline hydrochloride 0.5 mg/ml;   - nasal spray solution - active: ipratropium bromide 0.6 mg/ml xylometazoline hydrochloride 0.5 mg/ml   excipient: disodium edetate glycerol hydrochloric acid purified water sodium hydroxide - for the short term use for symptomatic relief of nasal congestion and rhinorrhoea associated with the common cold and acute phases of allergic rhinitis